Railway Pension Investments LTD Gilead Sciences, Inc. Transaction History

Railway Pension Investments LTD

$8.25 Billion
Q2 2024

A detailed history of Railway Pension Investments LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Railway Pension Investments LTD holds 1,484,165 shares of GILD stock, worth $133 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares

1,484,165

Previous 1,563,965 5.1%

Holding current value

$133 Million

Previous $115 Million 11.11%

% of portfolio

1.23%

Previous 1.13%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$63.15 - $72.88 $5.04 Million - $5.82 Million	-79,800 Reduced 5.1%	1,484,165 $102 Million
Q1 2024 Jun 07, 2024	BUY	$71.58 - $87.29 $343,584 - $418,992	4,800 Added 0.31%	1,563,965 $115 Million
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $21.9 Million - $24.9 Million	-299,300 Reduced 16.1%	1,559,165 $126 Million
Q3 2023 Oct 25, 2023	SELL	$73.94 - $80.67 $18.1 Million - $19.7 Million	-244,500 Reduced 11.63%	1,858,465 $139 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $39.7 Million - $45.3 Million	-522,300 Reduced 19.9%	2,102,965 $162 Million
Q1 2023 May 09, 2023	BUY	$77.31 - $88.08 $14.4 Million - $16.4 Million	186,500 Added 7.65%	2,625,265 $218 Million
Q4 2022 Aug 11, 2023	SELL	$62.32 - $89.47 $11.6 Million - $16.7 Million	-186,500 Reduced 7.1%	2,438,765 $209 Million
Q4 2022 Jan 27, 2023	BUY	$62.32 - $89.47 $16.6 Million - $23.8 Million	266,100 Added 12.25%	2,438,765 $0
Q3 2022 Nov 15, 2022	BUY	$59.54 - $68.01 $529,906 - $605,289	8,900 Added 0.41%	2,172,665 $134 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $559,884 - $630,597	9,700 Added 0.45%	2,163,765 $134 Million
Q1 2022 Apr 25, 2022	SELL	$57.92 - $72.58 $306,976 - $384,674	-5,300 Reduced 0.25%	2,154,065 $128 Million
Q4 2021 Jan 25, 2022	BUY	$64.88 - $73.64 $3.79 Million - $4.3 Million	58,400 Added 2.78%	2,159,365 $157 Million
Q3 2021 Oct 26, 2021	BUY	$67.69 - $73.03 $3.84 Million - $4.15 Million	56,800 Added 2.78%	2,100,965 $147 Million
Q2 2021 Jul 23, 2021	BUY	$63.47 - $69.35 $2.77 Million - $3.02 Million	43,600 Added 2.18%	2,044,165 $141 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $20.8 Million - $23.8 Million	347,251 Added 21.0%	2,000,565 $129 Million
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $23 Million - $26.2 Million	-406,600 Reduced 19.74%	1,653,314 $96.3 Million
Q3 2020 Oct 29, 2020	BUY	$62.1 - $78.08 $4.03 Million - $5.07 Million	64,900 Added 3.25%	2,059,914 $130 Million
Q2 2020 Jul 22, 2020	BUY	$72.34 - $84.0 $19.6 Million - $22.8 Million	271,300 Added 15.74%	1,995,014 $153 Million
Q1 2020 Apr 22, 2020	BUY	$62.63 - $80.22 $4.87 Million - $6.23 Million	77,700 Added 4.72%	1,723,714 $129 Million
Q4 2019 Feb 03, 2020	BUY	$61.62 - $67.78 $375,820 - $413,390	6,099 Added 0.37%	1,646,014 $107 Million
Q3 2019 Oct 24, 2019	BUY	$62.51 - $69.0 $41 Million - $45.2 Million	655,316 Added 66.56%	1,639,915 $104 Million
Q2 2019 Oct 03, 2019	BUY	$61.87 - $69.38 $60.9 Million - $68.3 Million	984,599 New	984,599 $66.5 Million
Q2 2019 Jul 16, 2019	SELL	$61.87 - $69.38 $62 Million - $69.5 Million	-1,001,653 Closed	0 $0
Q1 2019 Oct 03, 2019	BUY	$62.53 - $70.05 $62.6 Million - $70.2 Million	1,001,653 New	1,001,653 $65.1 Million
Q1 2019 Apr 08, 2019	SELL	$62.53 - $70.05 $53.9 Million - $60.3 Million	-861,270 Closed	0 $0
Q4 2018 Oct 03, 2019	BUY	$60.54 - $79.0 $52.1 Million - $68 Million	861,270 New	861,270 $53.9 Million

Others Institutions Holding GILD

# of Institutions

1,905

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Railway Pension Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Railway Pension Investments LTD with notifications on news.

Account

Railway Pension Investments LTD Gilead Sciences, Inc. Transaction History